Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Deficits in Middle-to-Old Aged Bipolar II Disorder
NCT04035798Phase 3Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Aug 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in Bipolar II disorder (BP-II), sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
memantine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT04035798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035798.